Showing results (391-400 of 406) with videos related to

Sort By:
Pageof 41
Nature Communications|July 14, 2026
Distinct molecular subgroups in pediatric and young-onset meningiomas require age-adapted risk stratificationNatalie Berghaus, Arnault Tauziède-Espariat, Thomas Hielscher, et al.
Acta Neuropathologica Communications|August 30, 2020
Comprehensive analysis of diverse low-grade neuroepithelial tumors with FGFR1 alterations reveals a distinct molecular signature of rosette-forming glioneuronal tumorCalixto-Hope G Lucas, Rohit Gupta, Pamela Doo, et al.
Acta Neuropathologica|May 21, 2014
CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entityTara Spence, Patrick Sin-Chan, Daniel Picard, et al.
Research Square|March 30, 2023
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responsesDavid Raleigh, William Chen, Abrar Choudhury, et al.
Neuro-Oncology|January 22, 2026
Intracranial mesenchymal tumor, FET::CREB fusion-positive: an integrative analysis of 81 casesSharika Rajan, Hye-Jung Chung, Zhichao Wu, et al.
Neuro-Oncology|May 2, 2024
Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patientsJustin Z Wang, Alexander P Landry, David R Raleigh, et al.
Acta Neuropathologica|November 27, 2022
Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplificationMichaela-Kristina Keck, Martin Sill, Andrea Wittmann, et al.
Nature Medicine|November 9, 2023
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responsesWilliam C Chen, Abrar Choudhury, Mark W Youngblood, et al.
Cancer Discovery|August 16, 2023
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic PathwaysSriram Venneti, Abed Rahman Kawakibi, Sunjong Ji, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2026
Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-mutant: An International Multi-Institutional StudyCameron Crowell, Nikhil P Mankuzhy, Julie Bennett, et al.
Pageof 41